Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

SHE:000766 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Income	24.59	34.29	56.44	43.93	30.15	35.27
Depreciation & Amortization	61.14	62.24	66.94	74.74	71.62	69.39
Other Amortization	0.87	0.68	0.44	0.29	0.18	0.61
Loss (Gain) From Sale of Assets	-0	0.05	0.17	0.21	0.02	-0.83
Asset Writedown & Restructuring Costs	0.49	0.28	-0.12	-0.22	0.11	0.59
Loss (Gain) From Sale of Investments	-5.57	-5.18	-2.42	2.61	-1.3	-11.13
Provision & Write-off of Bad Debts	1.48	-0.63	3.65	8.98	-3.09	-3.19
Other Operating Activities	89.31	84.58	86.83	82.54	91.05	89.12
Change in Accounts Receivable	-42.49	-7.47	2.64	-50.56	-	-5.87
Change in Inventory	18.7	18.01	-10.47	10.18	4.12	54.74
Change in Accounts Payable	-67.48	-84.83	-42.8	-60.45	3.03	-116.27
Operating Cash Flow	83.56	105.05	162.75	112.78	198.16	138.33
Operating Cash Flow Growth	-58.77%	-35.45%	44.31%	-43.09%	43.25%	71.40%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Capital Expenditures	-55.93	-64.07	-49.17	-26.67	-23.74	-25.48
Sale of Property, Plant & Equipment	0.03	0.03	0.05	0.33	1.59	1.01
Cash Acquisitions	-	-	-	-	-	0.03
Divestitures	-	-	-	-	-	16.68
Investment in Securities	0	0	0	-0.93	0.91	0.01
Other Investing Activities	25.18	25.18	-	100.4	-	12
Investing Cash Flow	-30.72	-38.85	-49.12	73.13	-21.24	4.25

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Long-Term Debt Issued	-	1,853	234.5	130	1,607	40
Long-Term Debt Repaid	-	-1,840	-135.87	-227.45	-1,663	-296.9
Net Debt Issued (Repaid)	178.35	12.64	98.63	-97.45	-55.82	-256.9
Common Dividends Paid	-83.15	-81.32	-84.98	-83.32	-88.6	-97.5
Other Financing Activities	-0.21	-0.13	-20.55	-73.09	-	-
Financing Cash Flow	94.99	-68.8	-6.89	-253.86	-144.42	-354.4

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Cash Flow	147.83	-2.6	106.73	-67.95	32.5	-211.82

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Free Cash Flow	27.63	40.99	113.58	86.11	174.42	112.85
Free Cash Flow Growth	-82.62%	-63.91%	31.89%	-50.63%	54.56%	83.35%
Free Cash Flow Margin	2.56%	3.50%	8.59%	5.85%	11.86%	7.45%
Free Cash Flow Per Share	0.03	0.05	0.12	0.10	0.17	0.13
Levered Free Cash Flow	-36.4	-38.69	-21.21	28.71	96.14	112.66
Unlevered Free Cash Flow	16.15	12.49	31.91	80.68	151.64	173.41

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash Income Tax Paid	137.88	153.54	85.12	115.33	85.7	96.82
Change in Working Capital	-88.73	-71.24	-49.18	-100.31	9.43	-41.51

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error